⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Supplementary Figure S7 from Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma During Targeted Therapy

Alberto González‐Medina María Vila-Casadesús Marina Gómez-Rey Carles Fabregat-Franco Alexandre Sierra Tian V. Tian Florian Castet Gloria Castillo Judit Matito Paola Martínez Josep M. Miquel Paolo Nucíforo Raquel Pérez-López Teresa Macarulla Ana Vivancos

View at Publisher

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S7. Blind testing of VHIO-iCCA panel in 30 patients, analyzed prospectively.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

González‐Medina et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efee79 https://doi.org/10.1158/1078-0432.27142449

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S2 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
2Supplementary Figure S4 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
3Supplementary Figure S10 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
4Supplementary Figure S9 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
5Supplementary Figure S5 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024

More related papers

Supplementary Figure S6 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
Supplementary Figure S1 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024
Supplementary Figure S8 from Clinical Value of Liquid Biopsy in Patients with <i>FGFR2</i> Fusion–Positive Cholangiocarcinoma During Targeted Therapy2024